Complex Problems or Simple Solutions? Enhancing Evidence-Based Economics to Reflect Reality

Evidence-Based Decisions and Economics: Health Care, Social Welfare, Education and Criminal Justice, Second Edition

Volumn , Issue , 2010, Pages 162-172

  Lessard, Chantale ^a   Birch, Stephen ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Changing research paradigms enhancing problem solving; Economic analysis field implications; Enhancing evidence based economics reflecting reality; Establishing evidence of effectiveness evidence based approach to decision making; Health care decision making reality and complexity

Indexed keywords

EID: 79953090500     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444320398.ch13     Document Type: Chapter

References (82)

1. American Managed Care Pharmacy (AMCP). The AMCP Format for Formulary Submissions. A format for submission of clinical and economic data in support of formulary consideration by health care systems in the United States (Version 2.1). Alexandria, VA: Foundation for Managed Care Pharmacy, 2005.
2. Canadian Agency for Drugs and Technologies in Health (CADTH). Guidelines for the Economic Evaluation of Health Technologies: Canada, 3rd edn. Ottawa: Canadian Agency for Drugs and Technologies in Health, 2006.
3. Commonwealth Department of Health and Aging (CDHA). Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee, Including Major Submissions Involving Economic Analyses. Canberra: Commonwealth of Australia, 2002.
4. National Institute for Health and Clinical Excellence (NICE). Guide to the Methods of Technology Appraisal. London: National Institute for Health and Clinical Excellence, 2008.
5. Donaldson C, Mugford M, Vale L (eds). Evidence-Based Health Economics: from effectiveness to efficiency in systematic review. London, BMJ Books, 2002.
6. Birch S, Gafni A. Evidence-based health economics. Answers in search of questions? In: Kristiansen IS, Mooney G (eds) Evidence-Based Medicine in Its Place. Adington: Routledge, 2004.
7. Birch S. As a matter of fact: evidence-based decision-making unplugged. Health Economics 1997; 6(6): 547-559.
8. Carr-Hill R. Welcome? To the brave new world of evidence based medicine. Social Science and Medicine 1995; 41(11): 1467-1468.
9. Lessard C. Complexity and reflexivity: two important issues for economic evaluation in health care. Social Science and Medicine 2007; 64(8): 1754-1765.
10. Biswas R, Umakanth S, Strumberg J, Martin CM, Hande M, Nagra JS. The process of evidence-based medicine and the search for meaning. Journal of Evaluation in Clinical Practice 2007; 13(4): 529-532.
11. Grossman M. On the concept of health capital and the demand for health. Journal of Political Economy 1972; 80(2): 223-255.
12. Evans RG, Stoddart GL. Producing health, consuming health care. Social Science and Medicine 1990; 31(12): 1347-1363.
13. Holt TA (ed). Complexity for Clinicians. Abingdon: Radcliffe Medical Press, 2004.
14. Kernick D (ed). Complexity and Health care Organisation: a view from the street. Abingdon: Radcliffe Medical Press, 2004.
15. Plsek PE, Greenhalgh T. Complexity science: the challenge of complexity in health care. British Medical Journal 2001; 323(7313): 625-628.
16. Sweeney K, Griffiths F (eds). Complexity and Health care: an introduction. Abingdon: Radcliffe Medical Press, 2002.
17. Kernick D. Health economics and insights from complexity theory. In: Kernick D (ed) Getting Health Economics into Practice. Adington: Routledge, 2002.
18. Sanderson I. Complexity, 'practical rationality'and evidencebased policy making. Policy and Politics 2006; 34(1): 115-132.
19. Shiell A, Hawe P, Gold L. Complex interventions or complex systems? Implications for health economic evaluations. British Medical Journal 2008; 336(7656): 1281-1283.
20. Wilson T, Holt T, Greenhalgh T. Complexity science: complexity and clinical care. British Medical Journal 2001; 323(7314): 685-688.
21. Standish RK. Concept and definition of complexity. In: Yang A, Shan Y (eds) Intelligent Complex Adaptive Systems. Hershey, PA: IGI Publishing, 2008.
22. Medical Research Council (MRC). Developing and Evaluating Complex Interventions: a new guidance. London: Medical Research Council, 2008.
23. Craig P, Dieppe P, Macintyre S, Mitchie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. British Medical Journal 2008; 337: 979-983.
24. Healy SA. Changing science and ensuring our future. Futures 1997; 29(6): 505-517.
25. Ferlie E, Fitzgerald L, Wood M. Getting evidence into clinical practice: an organisational behaviour perspective. Journal of Health Services Research and Policy 2000; 5(2): 96-102.
26. Arber S, McKinlay J, Adams A, Marceau L, Link C, O'Donnell A. Patient characteristics and inequalities in doctors'diagnostic and management strategies relating to CHD; a video-simulation experiment. Social Science and Medicine 2006; 62(1): 103-115.
27. Landon BE, Reschovsky J, Reed M, Blumental D. Personal, organizational, and market level influences on physicians'practice patterns: results of a national survey of primary care physicians. Medical Care 2001; 39(8): 889-905.
28. Lutfey KE, Campbell SM, Renfrew MR, Marceau LD, Roland M, McKinlay JB. How are patient characteristics relevant for physicians'clinical decision making in diabetes? An analysis of qualitative results from a cross-national factorial experiment. Social Science and Medicine 2008; 67(9): 1391-1399.
29. McKinlay J, Link C, Arber S, Marceau L, O'Donnell A, Adams A. How do doctors in different countries manage the same patient? Results of a factorial experiment. Health Services Research 2006; 41(6): 2182-2200.
30. Von dem Knesebeck O, Bönte M, Siegrist J, et al. Country differences in the diagnosis and management of coronary heart disease-a comparison between the US, the UK and Germany. BMC Health Services Research 2008; 8: 198.
31. Harris MI. Health care and health status and outcomes for patients with type 2 diabetes. Diabetes Care 2000; 23(6): 754-758.
32. Watkins C, Harvey I, Carthy P, Moore L, Robinson E, Brawn R. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey. Quality and Safety in Health care 2003; 12(1): 29-34.
33. Rubin RR, Peyrot M, Siminerio LM. Health care and patient-reported outcomes: results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study. Diabetes Care 2006; 29(6): 1249-1255.
34. Coyle D. Increasing the Impact of Economic Evaluations on Health Care Decision-Making. Discussion Paper 108. York: Centre for Health Economics, 1993.
35. Haines A, Donald A (eds). Getting Research Findings into Practice, 2nd edn. London: BMJ Publishing Group, 2004.
36. Straus SE, Richardson WS, Glasziou P, Haynes RB. Evidence-Based Medicine: how to practice and teach EBM, 3rd edn. Edinburgh: Churchill Livingstone, 2005.
37. Greenhalgh T. Intuition and evidence-uneasy bedfellows? British Journal of General Practice 2002; 52(478): 395-400.
38. Drummond M, Brown R, Fendrick AM, et al., for the ISPOR Task Force. Use of pharmacoeconomics information-report of the ISPOR Task Force on use of pharmacoeconomic/ health economic information in health care decision making. Value in Health 2003; 6(4): 407-416.
39. Eddama O, Coast J. A systematic review of the use of economic evaluation in local decision-making. Health Policy 2008; 86(2-3): 129-141.
40. Späth HM, Allenet B, Carrère MO. L'utilisation de l'information économique dans le secteur de la santé: le choix des médicamentsàinclure dans les livrets thérapeutiques hospitaliers. Journal d'Economie Médicale 2000; 18(3-4): 147-161.
41. Van Velden ME, Severens JL, Novak A. Economic evaluations of health care programmes and decision making: the influence of economic evaluations on different health care decision-making levels. Pharmacoeconomics 2005; 23(11): 1075-1082.
42. Walkom E, Robertson J, Newby D, Pillay T. The role of pharmacoeconomics in formulary decision-making. Formulary 2006; 41(8): 374-386.
43. Williams I, McIver S, Moore D, Bryan S. The use of economic evaluations in NHS decision-making: a review and empirical investigation. Health Technology Assessment 2008; 12(7).
44. Buxton MJ. Economic evaluation and decision making in the UK. Pharmacoeconomics 2006; 24(11): 1133-1142.
45. Eddama O, Coast J. Use of economic evaluation in local health care decision-making in England: a qualitative investigation. Health Policy 2009; 89(3): 261-270.
46. Coast J. Is economic evaluation in touch with society's health values? British Medical Journal 2004; 329(7476): 1233-1236.
47. Menzel P, Gold MR, Nord E, Pinto-Prades JL, Richardson J, Ubel P. Toward a broader view of values in cost-effectiveness analysis of health. Hastings Center Report 1999; 29(3): 7-15.
48. Nord E, Pinto JL, Richardson J, Menzel P, Ubel P. Incorporating societal concerns for fairness in numerical valuations of health programmes. Health Economics 1999; 8(1): 25-39.
49. Stolk EA, van Donselaar G, Brouwer WBF, Busschbach JJV. Reconciliation of economic concerns and health policy. Illustration of an equity adjustment procedure using proportional shortfall. Pharmacoeconomics 2004; 22(17): 1097-1107.
50. Birch S, Gafni A. Information created to evade reality (ICER): things we should not look to for answers. Pharmacoeconomics 2006; 24(11): 1121-1131.
51. Birch S, Gafni A. The biggest bang for the buck or bigger bucks for the bang: the fallacy of the cost-effectiveness threshold. Journal of Health Services Research and Policy 2006; 11(1): 46-51.
52. Gafni A, Birch S. Inclusion of drugs in provincial drug benefit programs: should 'reasonable decision'lead to uncontrolled growth in expenditures? Canadian Medical Association Journal 2003; 168(7): 849-851.
53. Gafni A, Birch S. Incremental cost-effectiveness ratios (ICERs): the silence of the lambda. Social Science and Medicine 2006; 62(9): 2091-2100.
54. Buxton MJ, Drummond MF, van Hout BA, et al. Modelling in economic evaluation: an unavoidable fact of life. Health Economics 1997; 6(3): 221-227.
55. Soto J. Health economic evaluations using decision analytic modeling. Principles and practices-utilization of a checklist to their development and appraisal. International Journal of Technology Assessment in Health care 2002; 18(1): 94-111.
56. Lee RC, Donaldson C, Cook LS. The need for evolution in health care decision modeling. Medical Care 2003; 41(9): 1024-1033.
57. Philips Z, Ginnelly L, Sculpher M, et al. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technology Assessment 2004; 8(36).
58. Cooper NJ, Coyle D, Abrams K, Mugford M, Sutton A. Use of evidence in decision models: an appraisal of health technology assessments in the UK since 1997. Journal of Health Services Research and Policy 2005; 10(4): 245-250.
59. Sheldon TA. Problems of using modelling in the economic evaluation of health care. Health Economics 1996; 5(1): 1-11.
60. Brennan A, Akehurst, R. Modelling in health economic evaluation. What is its place? What is its value? Pharmacoeconomics 2006; 24(11): 1043-1053.
61. Bourdieu P. The Social Structures of the Economy. Oxford: Polity Press, 2005.
62. Small N, Mannion R. A hermeneutic science: health economics and Habermas. Journal of Health Organisation and Management 2005; 19(3): 219-235.
63. Hall J, Birch S, Haas M. Creating health gains or widening gaps: the role of health outcomes. Health Promotion Journal of Australia 1996; 6(1): 4-6.
64. National Forum on Health. Canada Health Action: building on the legacy. Final Report Volume II: Creating a culture of evidence-based decision making. Ottawa: Health Canada, 1997. Available from: www.hc-sc.gc.ca/hcs-sss/pubs/renewalrenouv/1997-nfoh-fnss-v2/legacy_heritage5-eng.php.
65. Cohen AM, Stavri PZ, Hersh WR. A categorization and analysis of the criticisms of evidence-based medicine. International Journal of Medical Informatics 2004; 73(1): 35-43.
66. Goldenberg MJ. On evidence and evidence-based medicine: lessons from the philosophy of science. Social Science and Medicine 2006; 62(11): 2621-2632.
67. Mannion R, Small N. Postmodern health economics. Health care Analysis 1999; 7(3): 255-272.
68. Herman J. Beyond positivism: a metaphysical basis for clinical practice? Medical Hypotheses 1992: 39(1): 63-66.
69. Kneebone R. Total internal reflection: an essay on paradigms. Medical Education 2002; 36(6): 514-518.
70. Malterud K. Reflexivity and metapositions: strategies for appraisal of clinical evidence. Journal of Evaluation in Clinical Practice 2002; 8(2): 121-126.
71. Richardson J, McKie J. Empiricism, ethics and orthodox economic theory: what is the appropriate basis for decisionmaking in the health sector? Social Science and Medicine 2005; 60(2): 265-275.
72. Latour B, Woolgar S. Laboratory Life: the construction of scientific facts. Princeton: Princeton University Press, 1986.
73. Cilliers P. Complexity and Postmodernism: understanding complex systems. London: Routledge, 1998.
74. Frijda NH. The laws of emotions. American Psychologist 1988; 43(5): 349-358.
75. Vinik A. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy. Clinical Therapeutics 2007; 29(6, part 1): 1236-1257.
76. Munday DF, Johnson SA, Griffiths FE. Complexity theory and palliative care. Palliative Medicine 2003; 17(4): 308-309.
77. Miller WL, McDaniel RR Jr, Crabtree BF, Stange KC. Practice jazz: understanding variation in family practices using complexity science. Journal of Family Practice 2001; 50(10): 872-878.
78. Gabbay J, Le May A. Evidence based guidelines or collectively constructed 'mindlines?'. Ethnographic study of knowledge management in primary care. British Medical Journal 2004; 329(7473): 1013-1017.
79. Freidson E. Profession of Medicine: a study of sociology of applied knowledge. Chicago: University of Chicago Press, 1988.
80. Albrecht G, Freeman S, Higginbotham N. Complexity and human health: the case for a transdisciplinary paradigm. Culture, Medicine and Psychiatry 1998; 22(1): 55-92.
81. Moss S. Policy analysis from first principles. Proceedings of the National Academy of Sciences of the United States of America 2002; 99(suppl 3): 7267-7274.
82. Seely AJ, Macklem PT. Complex systems and the technology of variability analysis. Critical Care 2004; 8(6): R367-R384.